BPG is committed to discovery and dissemination of knowledge
Observational Study
©The Author(s) 2025.
World J Clin Pediatr. Dec 9, 2025; 14(4): 108920
Published online Dec 9, 2025. doi: 10.5409/wjcp.v14.i4.108920
Table 1 Overall clinical features of patients with Kawasaki disease
Parameters
Total group (n = 139)
Without CA lesions (n = 107)
With CA lesions (n = 32)
P value
Onset age (years), median (25%, 75%)3.0 (1.0, 5.0)3.0 (1.3, 5.5)1.0 (0.5, 3.4)0.004
Number of days of fever (days), median (25%, 75%)10.0 (5.0, 14.0)11.0 (7.0, 15.0)5.5 (3.0, 13.0)0.068
Male sex73 (53.0)49 (46.0)24 (75.0)0.003
Complete Kawasaki disease criteria62 (45.0)49 (46.0)13 (41.0)0.608
Neurological symptoms, including36 (26.0)24 (22.0)12 (37.0)0.088
Aseptic meningitis9 (6.5)5 (5.0)4 (12.0)0.116
Shock49 (35.0)38 (35.5)11 (34.0)0.906
Acute renal failure7 (5.0)4 (4.0)3 (9.0)0.203
Hematologic abnormalities7 (5.0)5 (5.0)2 (6.0)0.722
Polyserositis22 (16.0)18 (17.0)4 (12.0)0.560
Acute respiratory distress syndrome30 (22.0)18 (17.0)12 (38.0)0.012
Coronary thrombosis6 (4.3)06 (19.0)
Acute heart failure9 (6.5)6 (6.0)3 (9.0)0.450


Write to the Help Desk